New trends in photobiology (Invited review)
Photophysical and photobiological processes in the photodynamic therapy of tumours

https://doi.org/10.1016/S1011-1344(96)07428-3Get rights and content

Abstract

Photodynamic therapy (PDT) is an innovative and attractive modality for the treatment of small and superficial tumours. PDT, as a multi-modality treatment procedure, requires both a selective photosensitizer and a powerful light source which matches the absorption spectrum of the photosensitizer. Quadra Logic's Photofrin®, a purified haematoporphyrin derivative, is so far the only sensitizer approved for phase III and IV clinical trials. The major drawbacks of this product are the lack of chemical homogeneity and stability, skin phototoxicity, unfavourable physicochemical properties and low selectivity with regard to uptake and retention by tumour vs. normal cells. Second-generation photosensitizers, including the phthalocyanines, show an increased photodynamic efficiency in the treatment of animal tumours and reduced phototoxic side effects. At the time of writing of this article, there were more than half a dozen new sensitizers in or about to start clinical trials. Most available data suggest a common mechanism of action. Following excitation of photosensitizers to long-lived excited singlet and/or triplet states, the tumour is destroyed either by reactive ringlet oxygen species (type II mechanism) and/or radical products (type I mechanism) generated in an energy transfer reaction. The major biological targets of the radicals produced and of singlet oxygen are well known today. Nucleic acids, enzymes and cellular membranes are rapidly attacked and cause the release of a wide variety of pathophysiologically highly reactive products, such as prostaglandins, thromboxanes and leukotrienes. Activation of the complement system and infiltration of immunologically active blood cells into the tumorous region enhance the damaging effect of these aggressive intermediates and ultimately initiate tumour necrosis. The purpose of this review article is to summarize the up-to-date knowledge on the mechanisms responsible for the induction of tumour necrotic reactions.

References (172)

  • C.S. Foote

    Photosensitized oxidation and singlet oxygen: consequences in biological systems

  • T. Kriska et al.

    Physico-chemical modeling of the role of free radicals in photodynamic therapy. III. Interactions of stable free radicals with excited photosensitizers studied by kinetic ESR spectroscopy

    Biochem. Biophys. Res. Commun.

    (1995)
  • S.Yu. Egorov et al.

    Rise and decay kinetics of photosensitized singlet oxygen luminescence in water. Measurements with nanosecond time-correlated single photon counting technique

    Chem. Phys. Lett.

    (1989)
  • M. Shopova et al.

    Comparison of the photosensitizing efficiencies of haematoporphyrin (Hp) and its derivative (HpD) with that of free-base tetrasulphophthalocyanine (TSPC-H2) in homogeneous and microheterogeneous media

    J. Photochem. Photobiol. B: Biol.

    (1990)
  • H. van den Bergh

    Light and porphyrins in cancer therapy

    Chem. Br.

    (1986)
  • M.S. Patterson et al.

    In vivo tests of the concept of photodynamic threshold dose in normal rat liver photosensitized by aluminum chlorosulphonated phthalocyanine

    Photochem. Photobiol.

    (1990)
  • T. Takemura et al.

    Critical importance of the triplet lifetime of the photosensitizer in photodynandc therapy of tumors

    Photochem. Photobiol.

    (1989)
  • I. Rosenthal et al.

    Phthalocyanines in photobiology

  • D. Skalkos et al.

    Iminium salt benzochlorins as potential photosensitizers in photodynamic therapy

    Med. Chem. Res.

    (1992)
  • S.H. Selman et al.

    Copper benzochlorin, a novel photosensitizer for photodynamic therapy: effects on a transplantable urothelial tumor

    Photochem. Photobiol.

    (1993)
  • K.K. Iu et al.

    A time-resolved study of singlet molecular oxygen (14gO2 formation in a solution-phase photosensitized reaction: a new experimental technique to examine the dynamics of quenching by oxygen

    J. Phys. Chem.

    (1987)
  • M. Ochsner-Bruderer

    Zinc(II)-phthalocyanine,a photosensitizerfor photodynamic therapy of tumours

  • R. Schmidt et al.

    Time-resolved measurement of O2(1Σg+) in solution. Phosphorescence from an upper excited state

    J. Phys. Chem.

    (1994)
  • C. Milanese et al.

    Zn(II)-phthalocyanine as a photodynamic agent for tumours. II. Studies on the mechanism of photosensitized tumour necrosis

    Br. J. Cancer

    (1990)
  • M. Géze et al.

    Lysosomes, a key target of hydrophobic photosensitizers proposed for photochemotherapeutic applications

    J. Photochem. Photobiol. B: Biol.

    (1994)
  • T.G. Truscott

    Photochemistry of porphyrins and bile pigments in homogeneous solution

  • K. Schieweck et al.

    CGP 55847, liposome-delivered zinc(II)-phthalocyanine as a phototherapeutic agent for tumours

  • J.P. Thomas et al.

    Glucose administration augments in vivo uptake and phototoxicity of the tumor-localizing fraction of hematoporphyrin derivative

    Photochem. Photobiol.

    (1989)
  • L.W. Ma et al.

    Enhanced tumor uptake of meso (tetrahydroxyphenyl) chlorin by administration of glucose

    Photochem. Photobiol.

    (1996)
  • B.C. Wilson et al.

    Chromatographic analysis and tissue distribution of radiocopper-labelled haematoporphyrin derivatives

    Lasers Med. Sci.

    (1988)
  • H.L.L.M. van Leengoed et al.

    In vivo fluorescence kinetics of phthalocyanines in a skin-fold observation chamber model, role of central metal ion and degree of sulfonation

    Photochem. Photobiol.

    (1993)
  • D. Kessel et al.

    Tumor localization and photosensitization by sulfonated derivatives of tetraphenylporphine

    Photochem. Photobiol.

    (1987)
  • C.J. Tralau et al.

    Photodynamic therapy with phthalocyanine sensitization: quantitative studies in a transplantable rat fibrosarcoma

    Br. J. Cancer

    (1987)
  • C.J. Tralau et al.

    Aluminum sulfonated phthalocyanine distribution in rodent tumors of the colon, brain and pancreas

    Photochem. Photobiol.

    (1987)
  • W.-S. Chan et al.

    Effects of sulfonation on the cell and tissue distribution of the photosensitizer aluminum phthalocyanine

    Cancer Res.

    (1990)
  • S.G. Bown et al.

    Photodynamic therapy with porphyrin and phthalocyanine sensitisation: quantitative studies in normal rat liver

    Br. J. Cancer

    (1986)
  • N.A. Frigerio

    Metal phthalocyanines

    (1962)
  • G. Ara et al.

    Mechanism of mitochondria) photosensitization by the cationic dye, N,N′-bis(2-ethyl-1-3-dioxylene)-kryptocyanine (EDKC): preferential inactivation of complex I in the electron transport chain

    Cancer Res.

    (1987)
  • J.S. Modica-Napolitano et al.

    Mitochondrial toxicity of cationic photosensitizers for photochemotherapy

    Cancer Res.

    (1990)
  • H. von Ditfurth

    Im Anfang war der Wasserstoff

    (1981)
  • H. Cottier
  • R.A. La Biche et al.

    Transcripts of mitochondrial gene ND5 are overexpressed in highly metastatic murine large cell lymphoma cells

    In Vivo

    (1992)
  • H. Zarbl et al.

    Functional in vitro assays for the isolation of cell transformation effector and suppressor genes

    Environ. Health Perspect.

    (1991)
  • B.M. Kinsey et al.

    Absence of preferential uptake of [125I]iododihydrorhodamine 123 by four human tumor xenografts

    Cancer Res.

    (1989)
  • A.H. Cincotta et al.

    Novel benzophenothiazinium photosensitizers: preliminary in vivo results

  • B.W. Henderson et al.

    Possible implications of vascular damage for tumor cell inactivation in vivo: comparison of different photosensitizers

  • I. Rosenthal

    Phthalocyanines as photodynamic sensitizers

    Photochem. Photobiol.

    (1991)
  • V.H. Fingar et al.

    The effects of photodynamic therapy using differently substituted zinc phthalocyanines on vessel constriction, vessel leakage and tumor response

    Photochem. Photobiol.

    (1993)
  • J.A. Hampton et al.

    Mechanisms of cell killing in photodynamic therapy using a novel in vivo drug/in vitro light culture system

    Photochem. Photobiol.

    (1992)
  • B.W. Henderson et al.

    Tumor destruction and kinetics of tumor cell death in two experimental mouse tumours following photodynamic therapy

    Cancer Res.

    (1985)

    • Cited by (0)

    View full text
    Copyright © 1997 Published by Elsevier B.V.